Abiomed Receives HDE Supplement Approval for AbioCor(R) Artificial Heart.
Business Wire › January 22, 2008
Linked as:
Extract
Abiomed Receives HDE Supplement Approval for AbioCor(R) Artificial Heart.
* Approval Enables Commercial Launch in the United States
* AbioCor the Only Treatment Option for Bi-Ventricular Heart Failure Patients Not Eligible for Transplant DANVERS, Mass. -- Abiomed, Inc. (NASDAQ: ABMD) today announced that it has recei...See the full content of this document
Sponsored links
